Advanced search
Publication Cover
Leukemia & Lymphoma Volume 13, 1994 - Issue 1-2
Submit an article Journal homepage
10
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Retreatment of Chronic Lymphocvtic Leukemia with 2-Chlorodeoxyadenbsine (CdA) at Relapse Following CdA-induced Remission: No Acquired Resistance

Gunnar Juliusson Division of Clinical Hematology and Oncology Department of Medicine, Huddinge Hospital, Stockholm, Sweden; Department of Clinical Pharmacology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden
&
Jan Liliemark Division of Clinical Hematology and Oncology Department of Medicine, Huddinge Hospital, Stockholm, Sweden; Department of Clinical Pharmacology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden
Pages 75-80 | Received 26 Jun 1993, Published online: 01 Jul 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tadeusz Robak. (2001) Cladribine in the Treatment of Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 40:5-6, pages 551-564.
Read now
Maija ItÄLÄ & Kari Remes. (1996) The COP Regimen is not a Feasible Treatment for Advanced, Refractory Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 23:1-2, pages 137-141.
Read now

Articles from other publishers (16)

I. García-Escobar, J. Sepúlveda, D. Castellano & H. Cortés-Funes. (2011) Therapeutic management of chronic lymphocytic leukaemia. Critical Reviews in Oncology/Hematology 80:1, pages 100-113.
Crossref
Michael Fiegl, Florian Falkner, Michael Steurer, Niklas Zojer, Georg Hopfinger, Ferdinand Haslbauer, Guntram Winder, Daniela Voskova, Johannes Andel, Alois Lang, Yvona Brychtova, Jiri Mayer, Richard Greil & Günther Gastl. (2011) Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. Annals of Hematology 90:9, pages 1083-1091.
Crossref
Darren S. Sigal, Heather J. Miller, Ethan D. Schram & Alan Saven. (2010) Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood 116:16, pages 2884-2896.
Crossref
Tadeusz Robak, Krzysztof Jamroziak & Pawel Robak. (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69:17, pages 2415-2449.
Crossref
Tadeusz Robak. (2005) Therapy of Chronic Lymphocytic Leukaemia with Purine Nucleoside Analogues. Drugs & Aging 22:12, pages 983-1012.
Crossref
D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes & D. Milligan. (2004) Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. British Journal of Haematology 125:3, pages 294-317.
Crossref
Tadeusz Robak, Jerzy Z. Boński, Marek Kasznicki, Joanna Góra‐Tybor, Andrzej Hellmann, Lech Konopka, Anna Dmoszyńska, Jadwiga Dwilewicz‐Trojaczek & Dariusz Wołowiec. (2002) Re‐treatment with cladribine‐based regimens in relapsed patients with B‐cell chronic lymphocytic leukemia. European Journal of Haematology 69:1, pages 27-36.
Crossref
T Robak & M Kasznicki. (2002) Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 16:6, pages 1015-1027.
Crossref
S. Cara & I.F. Tannock. (2001) Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance. Annals of Oncology 12:1, pages 23-27.
Crossref
E Van Den Neste, I Louviaux, JL Michaux, A Delannoy, L Michaux, A Sonet, A Bosly, C Doyen, P Mineur, M André, N Straetmans, E Coche, C Venet, T Duprez & A Ferrant. (2000) Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. Leukemia 14:6, pages 1136-1142.
Crossref
Robak, Błoński, Kasznicki, Konopka, Ceglarek, Dmoszyńska, Soroka‐Wojtaszko, Skotnicki, Nowak, Dwilewicz‐Trojaczek, Tomaszewska, Hellmann, Lewandowski, Kuliczkowski, Potoczek, Zdziarska, Hansz, Kroll, Komarnicki, Hołowiecki & Grieb. (2001) Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients. British Journal of Haematology 108:2, pages 357-368.
Crossref
A. Delannoy. (1996) 2-Chloro-2′-deoxyadenosine: clinical applications in hematology. Blood Reviews 10:3, pages 148-166.
Crossref
Johann Gruber, Françoise Geisen, Roswitha Sgonc, Alexander Egle, Andreas Villunger, Guenther Boeck, Günther Konwalinka & Richard Greil. (1996) 2′,2′‐Difluorodeoxycytidine (Gemcitabine) Induces Apoptosis in Myeloma Cell Lines Resistant to Steroids and 2‐Chlorodeoxyadenosine (2‐CdA). Stem Cells 14:3, pages 351-362.
Crossref
G. Juliusson & J. Liliemark. (1996) Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia. Annals of Oncology 7:4, pages 373-379.
Crossref
S.A. Johnson. (1996) Purine analogues in the management of lymphoproliferative diseases. Clinical Oncology 8:5, pages 289-296.
Crossref
M.A. Dimopoulos, D. Weber, K.B. Delasalle, M. Keating & R. Alexanian. (1995) Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: Identification of prognostic factors. Annals of Oncology 6:1, pages 49-52.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.